A dual strain Bifidobacterium longum probiotic as part of the management of gastrointestinal and psychosocial symptoms in irritable bowel syndrome – results of a real-world experience programme. (China Gut Conference, Beijing, 20th May 2023) With Dr Fiona Kinnear MSc, PhD (RD)
Dr Fiona Kinnear is a registered dietitian and Global Medical Advisor at Novozymes OneHealth. She has a PhD in Health Sciences from the University of Bristol and has experience in medical affairs roles across the medical nutrition and biohealth industries, primarily working in clinical and real-world research. She has published a number of research articles in the field of nutrition, physical activity and behavioural interventions for individuals with genetic conditions.
Learning Objectives:
1. Understand the reclassification of IBS from a functional gut disorder to a disorder of gut-brain interaction2. Understand the importance of considering both psychosocial and gastrointestinal symptoms of IBS in the clinical management of IBS symptoms3. Review the results of a new real world research study which explored the effects of a dual strain Bifidobacterium longum probiotic upon psychosocial and gastrointestinal symptoms of IBSRecommended for you…
CPD e-learning
0.5 CPD learning hour
CPD e-learning
1 CPD learning hour
Webinar on Demand
0.5 CPD learning hour
Clinical Summary
~5 minute read